Showing results (811-820 of 843) with videos related to
Sort By:
Pageof 85
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.The New England Journal of Medicine|April 6, 2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F Haynes, Peter B Gilbert, M Juliana McElrath, et al.Plos Pathogens|October 8, 2011
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsS Gnanakaran, Tanmoy Bhattacharya, Marcus Daniels, et al.Biorxiv : the Preprint Server for Biology|January 8, 2024
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.The Journal of Experimental Medicine|August 18, 2025
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodiesRyan S Roark, Rumi Habib, Jason Gorman, et al.Science Translational Medicine|June 11, 2025
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.Nature|April 5, 2013
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virusHua-Xin Liao, Rebecca Lynch, Tongqing Zhou, et al.Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.Mbio|January 11, 2023
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing AntibodiesFrederic Bibollet-Ruche, Ronnie M Russell, Wenge Ding, et al.Pageof 85